Skip to content
Disclosery

GENERAL ATLANTIC, L.P.

Follow

13F filer, CIK 1017645, New York, NY

GENERAL ATLANTIC, L.P. reported $2,148,421,589 across 12 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 99.84% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-26-001406

Period
2026-03-31
Reported value
$2.15B
Holdings
12
Top 10 weight
99.84%
New
0
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALKTadded+3,346,015$52.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ALHCexited-13,167,733-$260M
RVMDreduced-2,105,137-$205M
CNTAreduced-4,762,885-$189M
XPreduced-2,133,000-$40.6M
NRIXreduced-795,294-$12.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0000950142-26-001406, largest first. % of portfolio is the value over $2,148,421,589, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DLODLOCAL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 63,906,695 shares; 2024Q4: 63,906,695 shares; 2025Q1: 63,906,695 shares; 2025Q2: 63,906,695 shares; 2025Q3: 46,656,695 shares; 2025Q4: 46,656,695 shares; 2026Q1: 46,656,695 shares 46,656,695$605M28.17%0Timeline
CHYMCHIME FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 19,208,760 shares; 2025Q3: 19,208,760 shares; 2025Q4: 21,259,683 shares; 2026Q1: 21,259,683 shares 21,259,683$398M18.53%0Timeline
XPXP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 29,617,733 shares; 2024Q4: 29,617,733 shares; 2025Q1: 29,617,733 shares; 2025Q2: 25,517,733 shares; 2025Q3: 25,517,733 shares; 2025Q4: 22,699,133 shares; 2026Q1: 20,566,133 shares 20,566,133$392M18.23%-2,133,000Timeline
ALKTALKAMI TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,520,318 shares; 2024Q4: 9,645,318 shares; 2025Q1: 9,645,318 shares; 2025Q2: 9,645,318 shares; 2025Q3: 11,991,480 shares; 2025Q4: 11,991,480 shares; 2026Q1: 15,337,495 shares 15,337,495$240M11.19%+3,346,015Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,531,252 shares; 2024Q4: 7,531,252 shares; 2025Q1: 7,531,252 shares; 2025Q2: 7,531,252 shares; 2025Q3: 8,031,252 shares; 2025Q4: 8,031,252 shares; 2026Q1: 8,031,252 shares 8,031,252$227M10.56%0Timeline
EWCZEUROPEAN WAX CTR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 13,110,492 shares; 2024Q4: 13,110,492 shares; 2025Q1: 13,110,492 shares; 2025Q2: 13,110,492 shares; 2025Q3: 13,110,492 shares; 2025Q4: 13,110,492 shares; 2026Q1: 13,110,492 shares 13,110,492$75.8M3.53%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,474,428 shares; 2025Q4: 2,812,928 shares; 2026Q1: 707,791 shares 707,791$68.8M3.2%-2,105,137Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,897,159 shares; 2026Q1: 4,101,865 shares 4,101,865$63.6M2.96%-795,294Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,681,818 shares; 2024Q4: 9,681,818 shares; 2025Q1: 9,681,818 shares; 2025Q2: 9,681,818 shares; 2025Q3: 9,681,818 shares; 2025Q4: 6,117,715 shares; 2026Q1: 1,354,830 shares 1,354,830$53.8M2.5%-4,762,885Timeline
RSKDRISKIFIED LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,324,998 shares; 2024Q4: 5,324,998 shares; 2025Q1: 5,324,998 shares; 2025Q2: 5,324,998 shares; 2025Q3: 5,324,998 shares; 2025Q4: 5,324,998 shares; 2026Q1: 5,324,998 shares 5,324,998$20.9M0.97%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 936,020 shares; 2024Q4: 2,474,859 shares; 2025Q1: 2,474,859 shares; 2025Q2: 2,474,859 shares; 2025Q3: 2,474,859 shares; 2025Q4: 2,474,859 shares; 2026Q1: 2,474,859 shares 2,474,859$3.17M0.15%0Timeline
BULLWEBULL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,148,051 shares; 2025Q3: 7,198,867 shares; 2025Q4: 50,816 shares; 2026Q1: 50,816 shares 50,816$244K0.01%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALHCALIGNMENT HEALTHCARE INC13,167,733$260Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950142-26-001406 base2026-05-15acceptance time not in the bulk data set